Publications by authors named "J R Honey"
Objective: Musculoskeletal symptoms are commonly reported following acute COVID-19. It is unclear whether those with musculoskeletal symptoms subsequently develop inflammatory rheumatic musculoskeletal disease (iRMD). This review seeks to identify evidence for an association between acute COVID-19 and subsequent iRMD diagnosis.
View Article and Find Full Text PDFArticle Synopsis
- Brain-computer interfaces (BCI) rely on the connection between electrodes and neurons, but the foreign body reaction (FBR) to the electrodes can interfere with this connection and impact signal detection.
- Various factors can influence the size of the FBR, such as the animal's size, electrode shape, insertion technique, and use of drug-releasing electrodes.
- A systematic review of literature yielded 13 studies primarily focusing on larger animal models, showing over 30% reduction in inflammatory cells, but highlighted a lack of research linking FBR reduction to improved BCI functionality.
Objectives: To investigate the experiences and views of practitioners in the UK and Ireland concerning changes in bereavement care during the COVID-19 pandemic.
Design: Online survey using a snowball sampling approach.
Setting: Practitioners working in hospitals, hospices, care homes and community settings across the UK and Ireland.
Article Synopsis
- Antibody responses to SARS-CoV-2 usually appear in most infected individuals within 10-15 days after symptoms start, but it's unclear how long they last or if they protect against reinfection.
- The study analyzed serum samples from 65 confirmed cases over 94 days and found that over 95% of individuals developed various antibody types, with neutralizing antibodies detected after 8 days post-symptom onset.
- Results indicated that while some individuals retained high neutralizing antibody levels for more than 60 days, others experienced a significant decline, suggesting that booster vaccinations may be necessary for sustained protection against COVID-19.